Video
12 Sep 2023
Sympfiny® Multiparticulate Drug Delivery System
Content provided by our supplier
Röchling Medical Solutions SE
-
DE
-
2015On CPHI since
-
3Certificates
-
1000 - 4999Employees
Company types
Primary activities
Other Content from Röchling Medical Solutions SE (9)
-
News All German Röchling Medical sites now ISCC PLUS Certified
- The international standard gives customers access to renewable alternatives
- Transparency through mass balancing creates customer confidence
-
Whitepaper Patient-Centric Pharmaceutical Packaging Design
Many nations are experiencing a major demographic shift in which the over-60 population will soon outweigh younger age groups. An aging population has increasing implications for the healthcare system, as older adults are at a greater risk of chronic disease and often experience challenges with non-adherence to multiple medications. -
News Röchling Group invests EUR 50 million in Medical division
The Röchling Group is investing EUR 50 million in a new production building and production resources at its Röchling Medical site in Neuhaus am Rennweg, Germany. This is the world-leading plastics processor’s biggest investment to date in buildings and machinery. By making this investment, the Röchling Group is laying the course for the ongoing growth of its Medical division. The new building will create around 30 new jobs in Neuhaus, Thuringia. -
Video Experience our GMP-sites Brensbach and Neuhaus in Germany
Our sister GMP-sites in Brensbach and Neuhaus specialize in the development and manufacture of plastic primary packaging solutions for the pharmaceutical and diagnostic industries. We offer end-to-end support from product design to regulatory services. -
News Sympfiny® showcase in OnDrugDelivery: The advantages of multiparticulate drug formulations in paediatric medicine
Multiparticulates, an emerging technology with many advantages over traditional dosage forms are particularly suited for use in paediatric medicine. The Sympfiny® system is specifically tailored to administering multiparticulate drug formulations, thus opening up the way for more widesprad use of this novel dosage form in paediatrics. -
Brochure Röchling Medical Product Catalogue
Standard primary packaging solutions for solids, liquids and ophthalmologyContainers for diagnostics and analytics -
News Sympfiny® acceptability study among young children with positive results
Scientists at the University of Birmingham, UK have evaluated Sympfiny® as device for orally dispensing multiparticulate drugs to children aged 4-12. -
News Connect-e-Cap®: A pillbox that pays attention
Röchling Medical's innovative intelligent packaging solution against non-adherence.
Connect-e-Cap®- Reminds patients of the next required dose
- Records fill level, opening time etc.
- Recognizes the container via pairing function
- Reads out information regarding dosage, correct storage etc.
- Redefines communication between doctors and patients
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance